Open access · CC-BY
via OpenAlex
Solubleα-Klotho Serum Levels in Chronic Kidney Disease
Silverio Rotondi, Marzia Pasquali, Lida Tartaglione, Maria Luisa Muci, Giusy Mandanici, Cristiana Leonangeli, Silvia Sales, Alessio Farcomeni, Sandro Mazzaferro
International Journal of Endocrinology · 2015 · ▲ 93 citations
Abstract
Transmembrane α-Klotho (TM-Klotho), expressed in renal tubules, is a cofactor for FGF23-receptor. Circulating soluble-α-Klotho (s-Klotho) results from TM-Klotho shedding and acts on Phosphate (P) and Calcium (Ca) tubular transport. Decreased TM-Klotho, described in experimental chronic kidney disease (CKD), prevents actions of FGF23 and lessens circulating s-Klotho. Thus, levels of s-Klotho could represent a marker of CKD-MBD. To evaluate the clinical significance of s-Klotho in CKD we assayed serum s-Klotho and serum FGF23 in 68 patients (age 58 ± 15; eGFR 45 ± 21 mL/min). s-Klotho was lower than normal (519 ± 183 versus 845 ± 330 pg/mL, P < .0001) in renal patients and its reduction was detectable since CKD stage 2 (P < .01). s-Klotho correlated positively with eGFR and serum calcium (Cas) and negatively with serum phosphate (Ps), PTH and FGF23. FGF23 was higher than normal (73 ± 51 versus 36 ± 11, P < .0002) with significantly increased levels since CKD stage 2 (P < .001). Our data indicate a negative effect of renal disease on circulating s-Klotho starting very early in CKD. Assuming that s-Klotho mirrors TM-Klotho synthesis, low circulating s-Klotho seems to reflect the ensuing of tubular resistance to FGF23, which, accordingly, is increased. We endorse s-Klotho as an early marker of CKD-MBD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1155/2015/872193
- Canonical
- link ↗
- Fetched
- 2026-10-26 MST
Cite this
APA
Rotondi, S., Pasquali, M., Tartaglione, L., Muci, M.L., Mandanici, G., Leonangeli, C., Sales, S., Farcomeni, A., & Mazzaferro, S. (2015). Solubleα-Klotho Serum Levels in Chronic Kidney Disease. <em>International Journal of Endocrinology</em>. https://doi.org/10.1155/2015/872193
Vancouver
Rotondi S, Pasquali M, Tartaglione L, Muci ML, Mandanici G, Leonangeli C, et al. Solubleα-Klotho Serum Levels in Chronic Kidney Disease. International Journal of Endocrinology. 2015. doi:10.1155/2015/872193.
BibTeX
@article{silverio2015Solubl,
title = {Solubleα-Klotho Serum Levels in Chronic Kidney Disease},
author = {Silverio Rotondi and Marzia Pasquali and Lida Tartaglione and Maria Luisa Muci and Giusy Mandanici and Cristiana Leonangeli and Silvia Sales and Alessio Farcomeni and Sandro Mazzaferro},
journal = {International Journal of Endocrinology},
year = {2015},
doi = {10.1155/2015/872193},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nephrology Dialysis Transplantation 2012
Citation only
Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease
Menoufia Medical Journal 2018
Citation only
Evaluation of serum soluble klotho protein in patients with different degrees of chronic kidney disease
Toxins 2020
Open access · CC-BY
Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease
Journal of Investigative Medicine 2017
Citation only
Plasma S-Klotho is Related to Kidney Function and Predicts Adverse Renal Outcomes in Patients with Advanced Chronic Kidney Disease
The Egyptian journal of immunology 2026
Citation only
Impact of probiotic supplementation on serum klotho levels and inflammatory status in patients with diabetic kidney disease.
Journal of the American Society of Nephrology 2013
Citation only